ÂÜÀòÂÒÂ×

Michal Hershkovitz currently serves as VP at DarioHealth, a position held since February 2019. Prior to this role, Michal was VP at Exalenz Bioscience Ltd. from June 2018 to January 2019 and held the position of VP Clinical & Regulatory Affairs at Medinol from August 2008 to November 2017, successfully managing five multicenter global clinical studies and securing multiple regulatory approvals. Michal also worked at Teva Pharmaceuticals as Senior Director of Regulatory Affairs from June 1996 to November 2008, where a global team of over 40 regulatory professionals was established and managed. Michal holds a BSc in Chemical Engineering from the Technion - Israel Institute of Technology, obtained between 1979 and 1983.